Samjin Pharm (005500) — Free Cash Flow Generation Index
Samjin Pharm (005500) has a Free Cash Flow Generation Index of 0.64x as of June 2025. Free cash flow of ₩6.84 Billion represents 1% of operating cash flow (₩10.63 Billion). Explore Samjin Pharm capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Samjin Pharm Free Cash Flow Generation Index (2013–2024)
Historical FCF Generation Index trend for Samjin Pharm across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Samjin Pharm.
Annual Free Cash Flow Generation for Samjin Pharm (2013–2024)
Year-by-year Free Cash Flow Generation Index for Samjin Pharm. Check Samjin Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.52x | ₩19.81 Billion | ₩38.15 Billion | ₩18.34 Billion | ▲ +134.9% |
| 2023 | -1.49x | ₩-12.39 Billion | ₩8.33 Billion | ₩20.72 Billion | ▼ -41.2% |
| 2022 | -1.05x | ₩-18.20 Billion | ₩17.29 Billion | ₩35.50 Billion | ▲ +50.2% |
| 2021 | -2.11x | ₩-50.64 Billion | ₩23.97 Billion | ₩74.60 Billion | ▼ -648.3% |
| 2020 | -0.28x | ₩-6.74 Billion | ₩23.86 Billion | ₩30.60 Billion | ▼ -157.5% |
| 2019 | 0.49x | ₩11.59 Billion | ₩23.63 Billion | ₩12.04 Billion | ▼ -32.4% |
| 2018 | 0.73x | ₩21.85 Billion | ₩30.08 Billion | ₩8.24 Billion | ▼ -3.7% |
| 2017 | 0.75x | ₩28.11 Billion | ₩37.28 Billion | ₩8.86 Billion | ▼ -35.0% |
| 2016 | 1.16x | ₩56.46 Billion | ₩48.66 Billion | ₩7.80 Billion | ▼ -17.4% |
| 2015 | 1.40x | ₩26.60 Billion | ₩18.94 Billion | ₩7.66 Billion | ▼ -0.5% |
| 2014 | 1.41x | ₩45.76 Billion | ₩32.41 Billion | ₩13.35 Billion | ▼ -26.7% |
| 2013 | 1.93x | ₩14.20 Billion | ₩7.37 Billion | ₩6.83 Billion | — |